ConductScience.org, home

Paper6209513

High-dose intravenous gammaglobulin for Kawasaki disease.

Furusho K and 9 others. Lancet, 1984. Cited by 679 papers, by iCite.

Cite this record

ConductScience Library. High-dose intravenous gammaglobulin for Kawasaki disease. Papers, record 6209513. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6209513

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
High-dose intravenous gammaglobulin for Kawasaki disease.
PubMed
Journal
Lancet
PubMed
Year
1984
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
679
iCite
Relative citation ratio, by iCite
22.2
iCite
Revised in PubMed
2022-03-17
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Furusho KK
2Kamiya TT
3Nakano HH
4Kiyosawa NN
5Shinomiya KK
6Hayashidera TT
7Tamura TT
8Hirose OO
9Manabe YY
10Yokoyama TT

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Mucocutaneous Lymph Node SyndromeMajor topic
gamma-GlobulinsMajor topic
Acute Disease
Administration, Oral
Aspirin
Child, Preschool
Clinical Trials as Topic
Coronary Disease
Echocardiography
Female
Humans
Infant
Infusions, Parenteral
Male
Random Allocation

Source PubMed

Download CSV of topics

Cited by235

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 679 citations.

PMIDTitleJournalYearIn PapersSource
42964435Efficacy and Safety of Adjunctive Corticosteroids in Children With Kawasaki Disease: A Systematic Review and Meta-Analysis of Randomized Trials.Cardiol Res2026https://conductscience.org/library/papers/42964435PubMed
42550508Epidemiology of Kawasaki Disease After the COVID-19 Pandemic in Japan 2023-2024.JAMA Netw Open2026https://conductscience.org/library/papers/42550508PubMed
42511747The Autophagy-Inflammasome Axis as a Molecular Switch: From Persistent Inflammation to Vascular Remodeling in IVIG-Resistant Kawasaki Disease.Int J Mol Sci2026https://conductscience.org/library/papers/42511747PubMed
42086942Evolving strategies and unresolved challenges in IVIG resistance prediction models for Kawasaki disease.Pediatr Res2026https://conductscience.org/library/papers/42086942PubMed
41949774Predicting coronary artery abnormalities in Kawasaki disease: Model development and validation.Eur J Pediatr2026https://conductscience.org/library/papers/41949774PubMed
41762230Age-specific Association of Serum Albumin with Immunoglobulin Resistance and Coronary Artery Involvement in Kawasaki Disease.Pediatr Cardiol2026https://conductscience.org/library/papers/41762230PubMed
41670642Predicting the Need for Infliximab in Kawasaki Disease Using N-Terminal Pro-Brain Natriuretic Peptide at Diagnosis.Pediatr Cardiol2026https://conductscience.org/library/papers/41670642PubMed
41649640Thrombo-inflammation and Rethinking the Role of Aspirin in Kawasaki Disease.Curr Rheumatol Rep2026https://conductscience.org/library/papers/41649640PubMed
41491167Incomplete Kawasaki disease associated with acute icteric hepatitis and Torque teno virus infection: a case report and literature review.BMC Pediatr2026https://conductscience.org/library/papers/41491167PubMed
41436876Early differentiation of Kawasaki disease preceded by cervical lymphadenopathy from bacterial cervical lymphadenitis.Eur J Pediatr2025https://conductscience.org/library/papers/41436876PubMed
41312550MFG-E8 in Kawasaki Disease: Role in Endothelial Injury and Diagnostic Potential.J Inflamm Res2025https://conductscience.org/library/papers/41312550PubMed
41018844Echocardiographic Evaluation in Kawasaki Disease.J Med Ultrasound2025https://conductscience.org/library/papers/41018844PubMed
40934829Impaired cardiopulmonary functions in prepubertal patients with Kawasaki disease.Clinics (Sao Paulo)2025https://conductscience.org/library/papers/40934829PubMed
40636515Delineation of single-cell Altas provides new insights for development of coronary artery lesions in Kawasaki disease: bad and good signaling molecules.Front Pediatr2025https://conductscience.org/library/papers/40636515PubMed
40635748Impact of different treatment strategies on therapeutic efficacy and biomarkers in children with IVIG-resistant Kawasaki disease: a retrospective cohort study.Front Pharmacol2025https://conductscience.org/library/papers/40635748PubMed
40221756A visualized nomogram to predict intravenous immunoglobulin resistance in Kawasaki disease: a study based on the population in Southern China.Ital J Pediatr2025https://conductscience.org/library/papers/40221756PubMed
40084926Soluble Factors and Mechanisms Regulated by Sialylated IgG Signaling.Immunol Rev2025https://conductscience.org/library/papers/40084926PubMed
39941446Impact of a Concurrent Respiratory Virus Infection on the Clinical Presentation and Response to Initial Treatment of Kawasaki Disease: A Single-Center Observational Study.J Clin Med2025https://conductscience.org/library/papers/39941446PubMed
39905354Assessment of sleep problems in patients with Kawasaki disease: a survey-based study.BMC Pediatr2025https://conductscience.org/library/papers/39905354PubMed
39808233Establishment and validation of a nomogram for predicting intravenous immunoglobulin resistance and coronary artery lesion involvement in Kawasaki disease: a retrospective study.Clin Rheumatol2025https://conductscience.org/library/papers/39808233PubMed

See all 235 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6209513

GET https://conductscience.org/api/papers/v1/6209513/cited_by?page=2